Comparison of Adherence Between Nilotinib and Dasatinib As Second-Line Therapies in Chronic Myeloid Leukemia

MLA

Guerin, Annie, et al. “Comparison of Adherence Between Nilotinib and Dasatinib As Second-Line Therapies in Chronic Myeloid Leukemia.” Blood, vol. 118, no. 21, Nov. 2011, p. 2754. EBSCOhost, https://doi.org/10.1182/blood.V118.21.2754.2754.

APA

Guerin, A., Bollu, V. K., Guo, A., Stepner, M., Griffin, J. D., & Wu, E. Q. (2011). Comparison of Adherence Between Nilotinib and Dasatinib As Second-Line Therapies in Chronic Myeloid Leukemia. Blood, 118(21), 2754. https://doi.org/10.1182/blood.V118.21.2754.2754

Chicago

Guerin, Annie, Vamsi K Bollu, Amy Guo, Michael Stepner, James D Griffin, and Eric Qiong Wu. 2011. “Comparison of Adherence Between Nilotinib and Dasatinib As Second-Line Therapies in Chronic Myeloid Leukemia.” Blood 118 (21): 2754. doi:10.1182/blood.V118.21.2754.2754.